C. Kent Osborne, M.D. - Funding
Active
P50 CA58183 (Osborne) 9/30/92 - 11/30/08 34%
NIH/NCI
SPORE in Breast Cancer
The major goal of this large Specialized Program of Resource Excellence is
to expedite the translation of basic research into applied clinical applications
in breast cancer detection, treatment and prevention.
P01 CA30195 (Osborne) 8/1/97 - 12/31/03 0%
NIH/NCI
Markers of Breast Cancer Evolution and Progression
The major goal of this large Program Project is to identify prognostic factors
for making treatment decisions and the most effective methods for integrating
them into clinically useful models. This Program Project was extended for a
year without additional funds.
DAM.D. 17-02-1-0288 (Osborne) 7/1/02-6/31/05 10%
DOD
The Signaling Intermediate and Estrogen Receptor Co-Repressor FKHR
in the Pathogenesis of Breast Cancer
The major goals of this project are to map FKHR's functional domains and to
evaluate the importance of FKHR in normal mammary gland development.
Pending
P01 CA30195 (Osborne) 12/1/03
- 11/30/08 25%
NIH/NCI
Novel Gene Networks in Breast Development and Cancer
The major goals of this large Program Project are to.identify and characterize
the role of novel genetic pathways, which are found to be important in the
normal breast, in the pathogenesis and progression of human breast cancer.
Overlap
There is no scientific or budgetary overlap.